The pharma giant said amycretin led to weight loss and diabetes reductions in both injection and pill versions.

Orforglipron, a GLP-1 drug taken as a pill, achieved positive results in people with obesity and type 2 diabetes, although it ...

Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, ...

People taking weight loss injections are mistakenly eating too little, according to a pharmacist. Jason Murphy, head of ...

Novo Nordisk announced on Monday that it is lowering costs for weight loss and diabetes drugs, weeks after it struck a deal ...